{"text": ["Health", "Care", "Sector", "Update", "for", "02/16/2018:", "ABBV,APRI,UTHR,PCRX"], "created_at": "2018-02-16 21:40:50"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/16/2018:", "ABBV,APRI,UTHR,PCRX"], "created_at": "2018-02-16 21:40:50"}
{"text": ["AbbVie", "Inc.", "--", "Moody's", "says", "AbbVie's", "shareholder", "payouts", "are", "credit", "negative"], "created_at": "2018-02-16 20:48:26"}
{"text": ["How", "Cosentyx", "Resolves", "Enthesitis", "in", "Psoriatic", "Arthritis", "Patients"], "created_at": "2018-02-16 20:35:08"}
{"text": ["AbbVie", "Inc", "(ABBV)", "Files", "10-K", "for", "the", "Fiscal", "Year", "Ended", "on", "December", "31,", "2017"], "created_at": "2018-02-16 19:48:09"}
{"text": ["Novartis\u2019s", "Cosentyx", "May", "Emerge", "as", "a", "Leading", "Psoriasis", "Drug"], "created_at": "2018-02-16 19:05:02"}
{"text": ["Novartis\u2019s", "Cosentyx", "Emerged", "as", "Multi-Blockbuster", "Therapy", "in", "2017"], "created_at": "2018-02-16 17:33:27"}
{"text": ["Top-Rated", "Stocks:", "Zoetis", "Sees", "Composite", "Rating", "Climb", "To", "97"], "created_at": "2018-02-16 16:26:05"}
{"text": ["Top-Rated", "Stocks:", "Zoetis", "Sees", "Composite", "Rating", "Climb", "To", "97"], "created_at": "2018-02-16 16:26:05"}
{"text": ["Stocks", "To", "Watch:", "Bristol-Myers", "Squibb", "Sees", "RS", "Rating", "Jump", "To", "83"], "created_at": "2018-02-16 16:24:45"}
{"text": ["Stocks", "To", "Watch:", "Bristol-Myers", "Squibb", "Sees", "RS", "Rating", "Jump", "To", "83"], "created_at": "2018-02-16 16:24:45"}
{"text": ["AbbVie", "Announces", "New", "Phase", "2", "Data", "for", "Upadacitinib", "Showing", "Clinical", "and", "Endoscopic", "Outcomes", "in", "Crohn's", "Disease", "at", "52", "Weeks"], "created_at": "2018-02-16 16:20:00"}
{"text": ["Coca-Cola", "earnings", "show", "the", "beverage", "business\u2014not", "bottling\u2014is", "booming"], "created_at": "2018-02-16 15:44:32"}
{"text": ["AbbVie", "Hikes", "Dividend", "by", "35%,", "Launches", "$10B", "Buyback", "Plan"], "created_at": "2018-02-16 14:25:03"}
{"text": ["AbbVie", "Hikes", "Dividend", "by", "35%,", "Launches", "$10B", "Buyback", "Plan"], "created_at": "2018-02-16 14:25:03"}
{"text": ["Merck\u2019s", "Immunology", "and", "Cardiovascular", "Products", "in", "4Q17"], "created_at": "2018-02-16 14:02:38"}
{"text": ["AbbVie", "Hikes", "Dividend", "by", "35%,", "Launches", "$10B", "Buyback", "Plan"], "created_at": "2018-02-16 13:04:01"}
{"text": ["Did", "AbbVie,", "Inc.", "Just", "Become", "the", "Most", "Shareholder-Friendly", "Stock", "in", "America?"], "created_at": "2018-02-16 03:21:04"}
{"text": ["Did", "AbbVie,", "Inc.", "Just", "Become", "the", "Most", "Shareholder-Friendly", "Stock", "in", "America?"], "created_at": "2018-02-16 03:21:04"}
{"text": ["Did", "AbbVie,", "Inc.", "Just", "Become", "the", "Most", "Shareholder-Friendly", "Stock", "in", "America?"], "created_at": "2018-02-16 02:00:00"}
{"text": ["5", "Cheap", "Dividend", "Stocks", "with", "Growing", "Payouts"], "created_at": "2018-02-16 01:21:41"}
{"text": ["5", "Cheap", "Dividend", "Stocks", "with", "Growing", "Payouts"], "created_at": "2018-02-16 01:21:41"}
{"text": ["AbbVie", "Stock", "Rises", "After", "Increasing", "Dividend", "By", "35%"], "created_at": "2018-02-16 01:20:34"}
{"text": ["AbbVie", "Stock", "Rises", "After", "Increasing", "Dividend", "By", "35%"], "created_at": "2018-02-16 01:20:34"}
